FAM
ADVM

Fred Alger Management’s Adverum Biotechnologies ADVM Stock Holding History

Fred Alger Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,462
Closed -$151K – 466
2020
Q3 		$151K Sell
1,462
-1,038
-42% -$155K ﹤0.01% 402
2020
Q2 		$522K Buy
+2,500
New +$443K ﹤0.01% 397
2019
Q3 		– Sell
-5,101
Closed -$606K – 480
2019
Q2 		$606K Buy
+5,101
New +$422K ﹤0.01% 370
2015
Q4 		– Sell
-6,395
Closed -$527K – 570
2015
Q3 		$527K Buy
6,395
+4,450
+229% +$569K ﹤0.01% 430
2015
Q2 		$316K Buy
+1,945
New +$656K ﹤0.01% 485

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Fred Alger Management's ADVM Position: Q4 2020 in Review

Fred Alger Management sold out of Adverum Biotechnologies (ADVM) in Q4 2020, closing a stake of 1,462 shares — an estimated $151K sold.

Fred Alger Management first reported a position in ADVM in Q2 2015 and held it in 5 quarters. The position peaked at $606K in Q2 2019. 155 funds tracked by Wall St. Rank hold ADVM as of Q4 2020.

  • Fred Alger Management reported no remaining Adverum Biotechnologies position as of Q4 2020 after selling out during the quarter.
  • Fred Alger Management sold 1,462 Adverum Biotechnologies shares in Q4 2020, an estimated $151K.
  • Fred Alger Management first reported a position in Adverum Biotechnologies in Q2 2015 and held it in 5 quarters.
  • Fred Alger Management's Adverum Biotechnologies position peaked at $606K in Q2 2019.
  • 155 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2020.

Based on Fred Alger Management's 13F filing for Q4 2020, filed 16 Feb 2021.